Example: Heart Attack
Clinical Trials on Borderline Resectable Adenocarcinoma of the Head of the Pancrease
Total 9779 results
-
NCT05183425RecruitingExplore the Consistency of Drug Sensitivity Between Primary Colorectal Cancer and Liver Metastases
-
NCT05075499Recruiting
-
NCT04941079Not yet recruiting
-
NCT04758078RecruitingRespiratory Distress
-
NCT04425148RecruitingFrontotemporal Dementia
-
NCT04047628RecruitingRelapsing Multiple Sclerosis | Relapsing Remitting Multiple Sclerosis | Secondary Progressive Multiple Sclerosis
-
NCT02521311Recruiting
-
NCT04747431Active, not recruitingFrontotemporal Dementia | FTD | C9orf72 | Dementia Frontotemporal | FTD-GRN
-
NCT04010357CompletedSmall-cell Lung Cancer | Large Cell Neuroendocrine Carcinoma of the Lung | Extrapulmonary Small Cell Carcinoma
-
NCT02845323Active, not recruiting
-
NCT02255383Active, not recruitingOsteoarthritis | Rheumatoid Arthritis | Traumatic Arthritis | Knee Pain Chronic | Polyarthritis | Avascular Necrosis of the Femoral Condyle | Moderate Varus, Valgus or Flexion Deformities
-
-
NCT04695080Active, not recruitingProgressive Multiple Sclerosis | Advanced Multiple Sclerosis
-
NCT04115293CompletedMyasthenia Gravis, Generalized
-
NCT04224506WithdrawnMyasthenia Gravis | Myasthenia Gravis, Generalized
-
NCT05737160CompletedMyasthenia Gravis, Generalized
-
NCT04650854CompletedGeneralized Myasthenia Gravis
-
NCT04963270Terminated
-
NCT05226702CompletedDouble Vaccinated for COVID-19 (For Phase 1 of the Study) | Acute Respiratory Syndrome Coronavirus 2 (For Phase 2 Exploratory Group)
-
NCT05315661Active, not recruiting
-
NCT03260920Active, not recruitingFrontotemporal Dementia
-
NCT03574610CompletedMultiple Sclerosis | Neurogenic Bladder | Voiding Dysfunction
-
-
NCT04124965Completed
-
NCT03770403Completed
-
NCT02598895CompletedCastration-Resistant Prostate Carcinoma | Metastatic Prostate Carcinoma | Stage IV Prostate Cancer | PSA Progression | Castration Levels of Testosterone | Prostate Carcinoma Metastatic in the Bone
-
NCT04682548CompletedMultiple Sclerosis | Covid19
-
NCT04834401CompletedMultiple Sclerosis | Covid19
-
NCT03315130CompletedGeneralized Myasthenia Gravis
-
NCT04335201CompletedPatients With COVID-19 Pneumonia Will Allow to Detect an Absolute Reduction in the Rate of Respiratory-failure
-
NCT04758468CompletedMultiple Sclerosis | Urinary Incontinence
-
NCT02502396CompletedCancer | Pulmonary Embolism | Non-valvular Atrial Fibrillation | Deep-vein Thrombosis of the Lower and Upper Extremities
-
-
NCT04982289WithdrawnGeneralized Myasthenia Gravis
-
NCT05045248CompletedMyasthenia Gravis | Ocular Myasthenia Gravis
-
NCT04833673CompletedMultiple Sclerosis, Relapsing-Remitting | Fatigue Syndrome, Chronic | Pain, Chronic | Kinesiophobia
-
NCT04134299CompletedSickle Cell Disease | Anemia, Sickle Cell | Sickle Cell Anemia | To Assess the Safety and Tolerabiltiy of an Amino Acid Composition in Subjects With Sickle Cell Disease | Sickle Cell Disorders
-
NCT03197025TerminatedHuman Papillomavirus | HPV-16 | High Grade Squamous Intraepithelial Lesion
-
NCT01069861TerminatedPersistent Pulmonary Hypertension of the Newborn | Hypoxic Respiratory Failure | PPHN
-
NCT04674605UnknownMyasthenia Gravis | Myasthenia Gravis Crisis
-
NCT04061681CompletedMultiple Sclerosis | Restless Legs Syndrome
-
NCT01928225CompletedCervical High Grade Squamous Intraepithelial Lesion
-
NCT01554332UnknownNeuropathic Pain | Facial Pain | Post-stroke Pain | Brachial Plexus Avulsion | Phantom Limb Pain of the Upper Extremities
-
NCT02413580CompletedA Study to Assess the Efficacy and Safety of IGIV-C in Patients With Myasthenia Gravis ExacerbationsMyasthenia Gravis Exacerbations
-
NCT01997229CompletedRefractory Generalized Myasthenia Gravis
-
NCT02473952CompletedMyasthenia Gravis, Generalized
-
NCT01663753Completed
-
NCT01937013CompletedFrontotemporal Dementia
-
NCT03165435WithdrawnMyasthenia Gravis, Generalized
-
NCT00376051CompletedFrontotemporal Dementia